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ABSTRACT 
We present recommendations on performance and safety measures of ultrasound examinations in obstetrics and gynecol-
ogy during the SARS COV-2 pandemic. The statement was prepared based on the current knowledge on the coronavirus 
by the Ultrasound Section of the Polish Society of Obstetrics and Gynecology. It has to be noted that the presented guid-
ance is based on limited evidence and is primarily based on experiences published by authors from areas most affected by 
the virus thus far, such as China, Singapore, Hong Kong, and Italy. We realize that the pandemic situation is very dynamic. 
New data is published every day. Despite the imposed limitations related to the necessity of social distancing, it is crucial 
to remember that providing optimal care in safe conditions should remain the primary goal of healthcare providers. We 
plan to update the current guidelines as the situation develops.
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INTRODUCTION
Due to the current epidemiological situation related to 
the SARS CoV-2 pandemic to minimize the risk of coronavi-
rus transmission among ultrasound practitioners in Poland, 
the Ultrasound Section of the Polish Society of Gynecolo-
gists and Obstetricians has compiled recommendations 
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in the field of ultrasound examinations in obstetrics and 
gynecology. The aim is to present the most up to date infor-
mation on performance and safety measures of ultrasound 
examinations in obstetrics and gynecology during the SARS 
CoV-2 pandemic. The statement was prepared based on the 
current knowledge on the coronavirus and its known routes 
of transmission. The authors are a group of experts of the 
Ultrasound Section of the Polish Society of Obstetrics and 
Gynecology. It has to be noted that the presented guid-
ance is based on limited evidence and is primarily based on 
experiences published by authors from areas most affected 
by the virus thus far, such as China, Singapore, Hong Kong, 
and Italy [1]. 
RECOMMENDATIONS
Ultrasound Section of the Polish Society of Gynecolo-
gists and Obstetricians recommends the following in the 
field of ultrasound examinations in obstetrics and gyne-
cology:
1. An initial selection of patients should be made before 
carrying out an ultrasound examination by:
a) teleconsultation and completing a risk assessment 
of COVID-19 online with a questionnaire
or
b) telephone conversation with the patient and risk 
assessment by the reception employee 
or
c) completing a questionnaire and epidemiological 
risk assessment immediately after reporting to the 
ultrasound performing facility.
Only patients with a negative history and asymptomatic 
will be scanned. 
In the case of patients with an adverse epidemiological 
history, not feverish but with cold symptoms, it is advisable 
to postpone the examination until the symptoms subside.
It can be assumed that in mild cases, postponing the 
examination for 7 days should be sufficient.
2. Pregnant women with a positive history should be quar-
antined for 14 days and not have ultrasound screening. 
In case of emergency, hospital care in a COVID-19 dedi-
cated center is recommended. 
3. Pregnant women with COVID-19 or with a positive 
SARS-CoV-2 test should have ultrasound examina-
tions performed only for justified medical indications 
in multidisciplinary (so-called single-purpose) centers 
dedicated to caring for patients with SARS-CoV-2 infec-
tion (according to the list published by the Ministry of 
Health).
4. In a hospital setting, only clinically indicated examina-
tions should be performed. These principles should be 
adapted to the recommendations issued by the Polish 
Society of Gynecologists and Obstetricians and national 
specialists in the field of obstetrics/gynecology and peri-
natology [2–4]. 
5. In suspected, likely or confirmed cases of COVID-19 in-
fection, ultrasound examination of fetal growth, AFI, 
and umbilical artery blood flow should be performed 
when clinically necessary. Bedside testing is preferred. 
In the following weeks of pregnancy, the parameters, 
as mentioned above, should be monitored depending 
on the obstetric situation every 2–4 weeks [5, 6] (Tab. 1). 
6. If infection with COVID-19 is confirmed during the first 
or early second trimester, an ultrasound examination 
should be recommended between 18 and 24 weeks 
of pregnancy.
7. In outpatient settings, I, II, and III trimester exams should 
be performed. In emergencies, only if the examination 
cannot be performed in a hospital setting (acute ab-
domen, suspected ectopic pregnancy, adnexal tumor 
torsion, oncological patients, PID, bleeding from the 
genital tract of unknown etiology).
8. All other planned examinations should be postponed. 
(i.e., in particular 3D/4D, gynecological examinations 
and routine breast examinations, or monitoring of se-
lected symptoms in obstetrics — benign dilatation of 
lateral ventricles of the brain, renal pelvic dilatation).
9. During obstetric examinations, due to the increased 
risk of transmission during a vaginal ultrasound, the 
number of endovaginal probe examinations should 
be minimized. Also, throughout the time of the epide-
miological threat, cervical length should be assessed by 
a transabdominal examination. If the cervical length is 
less than 25 mm, we recommend vaginal progesterone. 
There is no need to verify the measurement with a trans-
vaginal probe. Avoid creating aerosols from potentially 
infectious material (vaginal discharge).
10. We carry out invasive testing following current recom-
mendations and guidelines [7]. 
11. It is required to shorten the duration of the ultrasound ex-
amination, by limiting the number of parameters assessed 
(e.g., temporarily refraining from Ductus Venosus and Tri-
cuspid Regurgitation assessment in fetuses with normal NT 
measurement in the first trimester of pregnancy) (Tab. 1).
12. It is required to limit the number of patients in the wait-
ing room and enforce a complete restriction on the 
presence of accompanying persons. It is also required to 
maintain a distance of at least 2 meters between people.
13. It is required to keep the distance between the patient 
and the sonographer as large as possible.
14. During an ultrasound examination, verbal and visual 
contact with the patient should be limited. Consultation 
of the ultrasound findings should take place after com-
pleting the exam. It is essential to keep a safe distance 
during verbal communication.
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15. Only the patient can stay in the office and waiting room 
— no accompanying persons. It is strictly prohibited, 
bringing children to the medical facility.
RECOMMENDED PERSONAL PROTECTIVE 
EQUIPMENT 
1. At least a surgical mask for the doctor and midwife, in 
case the staff is infected and asymptomatic, to avoid 
exposure of the pregnant woman. The mask also reduces 
the frequency of contact with the mouth and nose, 
which we often touch unknowingly. The availability of 
masks is limited. 
2. We recommend promoting safe behaviors. Every pa-
tient should attend the scan visit wearing a face mask. 
Many patients may be asymptomatic, causing a threat 
of spreading the virus while speaking. This threat is 
not only to medical practitioners but to other patients 
present in the facility. The virus lasts a long time in the 
air, and often there is no possibility of airing the office 
during the day. It is recommended to air the office sev-
eral times a day.
3. Protective goggles.
4. An ideal mask would be a mask with an FFFP2 (N95) or 
FFP3 (N100) filter. The availability of masks is limited.
5. Perform the ultrasound examination in disposable 
gloves.
6. Hand wash and disinfect after each examination — opti-
mally using a dispenser without aerosol production [8]!
CLEANING AND DISINFECTION OF 
THE DEVICE — ACCORDING TO THE 
MANUFACTURER’S INSTRUCTIONS
1. After each patient, use a cloth soaked in disinfectant to 
clean the probes and surfaces of the device. 
2. Since information about COVID-19 is incomplete, it is 
recommended to use high-level disinfectants 
3.  High-level disinfectants include:
a) ethanol 80–95% (exposure time 30 sec), 
b) 2-propanol 75–00% (exposure time 30 sec), 
c) 2-propanol and 1-propanol 45% and 30% (exposure 
time 30 sec), 
d) sodium hypochlorite 0.21% (Antisapril Blu 2%, ex-
posure time 30 sec),
e) glutaraldehyde 2.5% (exposure time 5 min), 
Table 1. Modification of routine examination depending on COVID-19 infection status/screening positive for symptoms/medical history/obstetric 
history and national guidelines for performance of routine ultrasound screening
Type of scan Asymptomatic/negative screening
Asymptomatic/positive 
screening
Symptomatic/positive 
screening 
Symptomatic/asymptomatic/
positive COVID-19
< 10 weeks
viability scan, 
pregnancy 
dating
Do not perform, unless heavy 
bleeding or pain;
consider in patients with high risk 
of abnormally invasive placenta*
Do not perform, unless 
heavy bleeding or pain;
Do not perform, unless 
heavy bleeding or pain;
Do not perform, unless heavy 
bleeding or pain; 
if necessary, ultrasound in 
dedicated one–purpose hospital
11–13.6 weeks
Combined test 
NT + PAPP–A + fBHCG, regardless 
of maternal age**
Offer NIPT
Reschedule combined 
test for at least two weeks 
if still within gestational 
age or CRL (45–84 mm, 
11–13.6 weeks)
Offer NIPT, without scan at 
11–13.6 weeks. Perform 
a detailed scan in 
3–4 weeks after quarantine
Reschedule combined 
test for at least two weeks 
if still within gestational 
age or CRL (45–84 mm, 
11–13.6 weeks)
Offer NIPT, without scan at 
11–13.6 weeks. Perform 
a detailed scan in 
3–4 weeks after quarantine
Reschedule combined test for 
at least two weeks if still within 
gestational age or CRL (45–84 mm, 
11–13.6 weeks)
Offer NIPT, without scan at 
11–13.6 weeks. Perform a detailed 
scan in 3–4 weeks after quarantine.
If necessary, perform ultrasound in 
a dedicated one-purpose hospital
18–22 weeks Anomaly scan
Reschedule after 
quarantine in 
2–3 weeks***
Reschedule after 
quarantine in 
2–3 weeks***
Reschedule after quarantine in 
2–3 weeks***
Fetal growth 
scan in the 
third trimester
28–32 weeks
Do not perform, unless clinically 
indicated; assess risk factors of 
fetal growth restriction during 
a teleconsultation;
Perform scan only in high-risk 
patients for abnormal fetal growth
Do not perform, unless 
clinically indicated; assess 
fetal growth 2–3 weeks 
after quarantine to screen 
for fetal growth restriction
Do not perform, unless 
clinically indicated; assess 
fetal growth 2–3 weeks 
after quarantine to screen 
for fetal growth restriction
Do not perform, unless clinically 
indicated; assess fetal growth 
2–3 weeks after quarantine to 
screen for fetal growth restriction
If necessary, perform ultrasound in 
a dedicated one–purpose hospital
Twin 
pregnancies
According to national ministerial 
recommendations
According to 
national ministerial 
recommendations; 
Perform scan in 2 weeks 
after quarantine
According to 
national ministerial 
recommendations;
Perform scan in 2 weeks 
after quarantine
According to national ministerial 
recommendations; Perform 
scan in 2 weeks after quarantine; if 
necessary, perform ultrasound in 
a dedicated one-purpose hospital
*Women with more than two cesarean sections, previous AIP, > 3 miscarriages with ECU or previous ectopic pregnancy; **in Poland the national prenatal screening 
program is free of charge only for women > 35 or with a previous or family history of congenital abnormalities; ***if high risk for abnormalities that fit the national laws 
for termination of pregnancy, inform the patient of time frame and rights if necessary perform ultrasound/invasive diagnosis in full protection
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f ) hydrogen peroxide 0.5% (REVITAL-OX RESERT, ex-
posure time 1 min).
4. Protective eyewear and gloves should be used when 
cleaning, disinfecting or sterilizing any equipment [1, 9]. 
SUMMARY
We realize that the pandemic situation is very dynamic. 
New data is published every day. Despite the imposed limita-
tions related to the necessity of social distancing, it is crucial 
to remember that providing optimal care in safe conditions 
should remain the main goal of healthcare providers. We 
plan to update the current guidelines as the situation develops.
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